Apr 16, 2012· Parenteral Drug Association (PDA) - Comment· FDA-2011-D-0611-0013
On behalf of the Parenteral Drug Association, we are pleased to submit comments on FDA's draft guidance on biosimilars in the matter of "Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009."